Ondansetron Hydrochloride Dihydrate (Zensana) is a selective serotonin 5-HT3 receptor antagonist used as an antiemetic for preventing nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative conditions. It works by blocking serotonin receptors in the central nervous system and gastrointestinal tract. Also referred to as (GR-38032F, and Ondansetron HCl Dihydrate or Ondansetron (hydrochloride dihydrate) by Ondansetron api manufacturers, it demonstrates high potency, oral bioavailability, and metabolic stability. We are the trusted Ondansetron Hydrochloride Dihydrate supplier worldwide, ensuring reliable lead times and consistent API quality for pharmaceutical manufacturing and clinical research.
Ondansetron Hydrochloride Dihydrate (Zensana) is a selective serotonin 5-HT3 receptor antagonist used as an antiemetic for preventing nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative conditions. It works by blocking serotonin receptors in the central nervous system and gastrointestinal tract. Also referred to as (GR-38032F, and Ondansetron HCl Dihydrate or Ondansetron (hydrochloride dihydrate) by Ondansetron api manufacturers, it demonstrates high potency, oral bioavailability, and metabolic stability. We are the trusted Ondansetron Hydrochloride Dihydrate supplier worldwide, ensuring reliable lead times and consistent API quality for pharmaceutical manufacturing and clinical research.
.3d8f8f41.svg)
Pharmaceutical
.3556d45a.svg)
Pharmaceutical Actives & Precursors
Active Pharmaceutical Ingredients (APIs)
.7767eb0f.png&w=3840&q=75){kind=small}
Chemical Properties & Specifications
H301 (100%), H318 (84.6%), H319 (11.1%), H400 (84.6%) H410 (82.9%)
P264, P264+P265, P270, P273, P280, P301+P316, P305+P351+P338, P305+P354+P338, P317, P321, P330, P337+P317, P391, P405, and P501
Prevention and treatment of nausea and vomiting in (Cancer chemotherapy), radiotherapy (Radiation therapy), and treat postoperative surgery (Postoperative care)
Selective 5-HT3 receptor antagonism reduces central and peripheral nausea signaling
Supports tablets, oral disintegrating tablets, and injectable dosage forms
Resistant to rapid metabolism, providing consistent therapeutic effects
Preferred in pharmacokinetic studies, 5-HT3 receptor studies, and preclinical antiemetic research
Suitable for API supply to pharmaceutical manufacturers, contract formulation & clinical research
Store at 15–25°C (59–77°F)
Protect from moisture and light; keep in tightly sealed containers